ANGIOTENSIN - ANVISA Registration 80464810514
Access comprehensive regulatory information for ANGIOTENSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810514 and manufactured by BEN BIOCHEMICAL ENTERPRISE SRL. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including LTA SRL, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80464810514
25351067248201701
09377976000152
Company Information
Dates and Status
Jul 31, 2017
VIGENTE
09/18/2025 19:00:01
ANGIOTENSINA
Família AutoLumo Angiotensina II Micropartículas (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513119
Oct 30, 2023
ANGIOTENSINA
Família Atellica CH Enzima Conversora de Angiotensina (ECA)
SENTINEL CH. SPA
10345162434
Mar 11, 2022
ANGIOTENSINA
ENZIMA CONVERSORA DE ANGIOTENSINA (ACE)
BIOSYSTEMS S.A.
80367750010
Sep 11, 2017
ANGIOTENSINA
MAGLUMI ANGIOTENSINA II (AII-CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102511806
Jun 19, 2017
ANGIOTENSINA
MAGLUMI ANGIOTENSINA I (AI) CLIA
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102511801
Jun 12, 2017

